[Experimental effect of ether, nitrous oxide, fluorothane, trichloroethylene, pentrane and cyclopropane anesthesia on respiration, oxidative phosphorylation and the amount of liver mitochondrial cytochromes]. 1978

A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar

UI MeSH Term Description Entries
D008733 Methoxyflurane An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180) Methofluranum,Anecotan,Penthrane,Pentrane
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D010085 Oxidative Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. Phosphorylation, Oxidative,Oxidative Phosphorylations,Phosphorylations, Oxidative
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D003580 Cytochromes Hemeproteins whose characteristic mode of action involves transfer of reducing equivalents which are associated with a reversible change in oxidation state of the prosthetic group. Formally, this redox change involves a single-electron, reversible equilibrium between the Fe(II) and Fe(III) states of the central iron atom (From Enzyme Nomenclature, 1992, p539). The various cytochrome subclasses are organized by the type of HEME and by the wavelength range of their reduced alpha-absorption bands. Cytochrome
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004986 Ether A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes. Diethyl Ether,Ether, Ethyl,Ethyl Ether,Ether, Diethyl
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan

Related Publications

A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
May 1979, British journal of anaesthesia,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
December 1969, Voenno-meditsinskii zhurnal,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
July 1953, American journal of surgery,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
April 1990, Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
August 1985, Toxicology,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
February 1954, The Journal of pharmacology and experimental therapeutics,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
February 1961, Therapie der Gegenwart,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
January 1965, Anesthesiology,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
January 1973, Farmakologiia i toksikologiia,
A A Tsyganiĭ, and L P Chepkiĭ, and Z G Ovrutskaia, and N A Medvinskaia, and V V Koziar
August 1969, Akusherstvo i ginekologiia,
Copied contents to your clipboard!